Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elena Sevillano-Fernández"'
Autor:
Elena Sevillano Fernández, Rodrigo Madurga de Lacalle, Juan Francisco Rodriguez Moreno, Arantzazu Barquín García, Mónica Yagüe Fernández, Paloma Navarro Alcaraz, María Barba Llacer, Miguel Quiralte Pulido, Jesús García-Donás Jiménez
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 15, p 4483 (2022)
Fibroblast growth factor receptor (FGFR) genomic alterations (GAs) represent an actionable target, key to the pathogenesis of some urothelial cancers (UCs). Though FGFR GAs are common in noninvasive UC, little is known about their role in the metasta
Externí odkaz:
https://doaj.org/article/dc11412cdbff443c821cf74bda6ffce2
Autor:
Paula Comune Pennacchi, Paloma Navarro, Verónica García Navas, Arántzazu Barquín García, Elena Sevillano Fernández, Sergio Ruiz Llorente, Juan Francisco Rodriguez, Monica Yagüe, Joan Ballesteros, Daniel Primo, Jesus Garcia Donas Jimenez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/9dcd0ffb4c1e47e2b2618082dc3d3a16
Autor:
María Dolores Fenor, Sergio Ruiz-Llorente, Juan Francisco Rodríguez-Moreno, Eduardo Caleiras, Juan Carlos Torrego, Elena Sevillano-Fernández, Paloma Navarro, Mónica Yagüe-Fernández, Sandra Amarilla-Quintana, Arantzazu Barquín, Jesús García-Donas
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 24(12)
The identification of subpopulations harboring druggable targets has become a major step forward in the subclassification of solid tumors into small groups suitable for specific therapies. BRAF fusions represent a paradigm of uncommon and targetable
Publikováno v:
Archivos espanoles de urologia. 71(3)
Prostate cancer is the most frequent malignant tumor in males in developed countries and represents the second cause of cancer death. Over the last years, the number of treatments available for patients with advanced prostate cancer has improved sign